| Previous Section | Index | Home Page |
13 Dec 2007 : Column 842W—continued
Health
Adult Dental Health Survey
Sir Paul Beresford: To ask the Secretary of State for Health (1) on what date the next Adult Dental Health Survey will be published; [173776]
(2) what funding his Department has committed to the forthcoming Adult Dental Health Survey. [173777]
Ann Keen: Responsibility for determining the way forward on the next Adult Dental Health survey rests with the Information Centre for health and social care (IC).
The IC is looking, with the Department and other stakeholders at the way forward. The funding requirements will be dependent on the outcome of these discussions and will feed into relevant organisations business planning for 2008-09 and subsequent years. We cannot yet predict when the results of the survey will be published.
Alcoholic Drinks: Misuse
Mr. Spring: To ask the Secretary of State for Health how many patients were admitted to (a) West Suffolk hospital, (b) Addenbrookes hospital and (c) Ipswich hospital as a consequence of (i) alcoholic liver disease and (ii) cirrhosis in each of the last five years. [170781]
Mr. Ivan Lewis: Information is not available by individual hospital rather it is collected for national health service trusts that the named hospitals are managed by. The following table shows the count of finished admission episodes at West Suffolk Hospital, Cambridge University Hospital National Health Service Foundation Trust (of which Addenbrookes Hospital is a part), and Ipswich Hospital.
Mr. Lansley: To ask the Secretary of State for Health what the (a) start and (b) end date is of each activity he has planned for next year to tackle excessive alcohol consumption; and what the expected cost is of each activity in each year for which expenditure is planned. [172466]
Dawn Primarolo: The start and end dates of planned activity to tackle excessive alcohol consumption next year are listed and described in detail with timescales in Annex B in The Government’s renewed alcohol strategy, “Safe. Sensible. Social”, published in June 2007. A copy is available in the Library.
The planned new actions and next steps involve a number of Government Departments as well as the national health service locally, and it is therefore not possible to fully set out expected costs.
The Department is spending £1.7 million in 2006-07 on the ‘Know your Limits’ campaign, which is a joint campaign with the Home Office who are contributing additional funding. In the case of the NHS, primary care trusts are responsible for delivering improvements to patient care, so spending on activity outlined in the strategy will be based on local decisions. We would also expect there to be scope for off-setting efficiency savings, for example from reduced hospital admissions.
Arthritis
Mr. Stephen O'Brien: To ask the Secretary of State for Health what the expenditure by (a) his Department’s research and development budget and (b) the Medical Research Council on research into rheumatoid arthritis was in each year since 1997-98. [172910]
Dawn Primarolo: Over the last 10 years, the main part of the Department’s total expenditure on health research has been devolved to and managed by national health service organisations.
Details of individual NHS supported research projects including a large number concerned with rheumatoid arthritis are available on the national research register at
In addition, the Department’s expenditure on national research programme projects specifically concerned with rheumatoid arthritis during this time has been as follows:
| £000 | |
Implementation of the Department’s research strategy “Best Research for Best Health” has led to an expansion of our research programmes and in significant new funding opportunities for health research. Work relevant to rheumatoid arthritis will for example be undertaken in several of the National Institute for Health Research Biomedical Research Centres (BRC). The Cambridge BRC has a musculoskeletal disorders research theme to which £2.2 million has been allocated over five years; and the Imperial College Healthcare NHS Trust BRC has a rheumatology research theme for which the total budget over five years is £2.7 million.
The Medical Research Council (MRC) is one of the main agencies through which the Government supports biomedical research. The MRC is an independent body funded by the Department for Innovation, Universities and Skills.
The MRC funds a large portfolio of research related to arthritis and rheumatism much of which will be of
relevance to rheumatoid arthritis. Available MRC expenditure figures for research relevant to arthritis and rheumatism are shown in the following table.
| Expenditure (£ million) | |
Arthritis: Drugs
Mr. Stephen O'Brien: To ask the Secretary of State for Health how many drugs for the treatment of rheumatoid arthritis were dispensed in the community in each year since 1997; and at what net ingredient cost. [172908]
Dawn Primarolo: The main drugs that can be used to treat rheumatoid arthritis are listed at paragraphs 10.1.1 (Non-steroidal anti-inflammatory drugs), 10.1.2 (Corticosteroids) and 10.1.3 (Rheumatic disease suppressant drugs) of the British National Formulary (BNF). The number of prescription items dispensed and associated net ingredient cost for drugs listed in these paragraphs are shown in the following tables. Some prescribing of these drugs will be for reasons other than rheumatoid arthritis (e.g. muscle strain) and there will be some prescribing from other areas of the BNF for the condition, e.g. BNF section 4.7 (Analgesics), which is not included.
| Prescription items dispen sed in the community, in England | ||||
| £000 | ||||
| BNF paragraph 10.1.1 | BNF paragraph 10.1.2 | BNF paragraph 10.1.3 | Total | |
| Source: Prescription cost analysis (PCA) system | ||||
| Net ingredient cost of prescription items dispensed in the community, in Engla nd | ||||
| £000 | ||||
| BNF paragraph 10.1.1 | BNF paragraph 10.1.2 | BNF paragraph 10.1.3 | Total | |
| Source: PCA system | ||||
| Next Section | Index | Home Page |